References

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

10.1212/01.wnl.0000253187.66183.9c · 2007 · External reference

COX-2-derived endocannabinoid metabolites as novel inflammatory mediators

10.1016/j.tips.2014.03.001 · 2014 · External reference

Cannabis sativa: much more beyond Δ(9)-tetrahydrocannabinol

10.1016/j.phrs.2020.104822 · 2020 · External reference

β-Caryophyllene, a CB2-receptor-selective phytocannabinoid, suppresses mechanical allodynia in a mouse model of antiretroviral-induced neuropathic pain

10.3390/molecules25010106 · 2019 · External reference

Priority areas for cannabis and cannabinoid product research in South Africa

10.4102/phcfm.v10i1.1711 · 2018 · External reference

Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials

10.36076/ppj.20.5.e755 · 2017 · External reference

Critical enzymes involved in endocannabinoid metabolism

10.2174/092986607780090829 · 2007 · External reference

Cannabis tourist destinations: risk for vulnerable travellers with pre-existing mental disorders

2019 · External reference

The Achilles heel of medical cannabis research-inadequate blinding of placebo-controlled trials

10.1001/jamainternmed.2017.5308 · 2018 · External reference

Endocannabinoid signaling and synaptic function

10.1016/j.neuron.2012.09.020 · 2012 · External reference

80 - Toxic and drug-induced neuropathies

2007 · External reference

Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats

10.1111/j.1745-7254.2007.00578.x · 2007 · External reference

Marijuana effectiveness as an HIV self-care strategy

10.1177/1054773809334958 · 2009 · External reference

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

10.1136/bmjopen-2018-024793 · 2019 · External reference

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

10.1038/384083a0 · 1996 · External reference

Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs

10.1007/bf02944294 · 1999 · External reference

Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment

10.2165/00003495-198800351-00004 · 1988 · External reference

Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal

10.1016/j.biopsych.2014.04.009 · 2015 · External reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

10.1126/science.1470919 · 1992 · External reference

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

10.1038/372686a0 · 1994 · External reference

Brain monoglyceride lipase participating in endocannabinoid inactivation

10.1073/pnas.152334899 · 2002 · External reference

Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Study (WIHS) cohort, 1994-2010

10.1097/qai.0b013e318273ab3a · 2012 · External reference

Cannabidivarin for HIV‐associated neuropathic pain: a randomized, blinded, controlled clinical trial

2020 · External reference

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial

10.1038/npp.2008.120 · 2009 · External reference

β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties

10.1002/cam4.816 · 2016 · External reference

The endocannabinoid system, cannabinoids, and pain

10.5041/rmmj.10129 · 2013 · External reference

Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner

10.1080/1475636021000049726 · 2003 · External reference

Cannabis and multiple sclerosis

10.1080/14737175.2020.1776610 · 2020 · External reference

Isolation, structure, and partial synthesis of an active constituent of hashish

10.1021/ja01062a046 · 1964 · External reference

Minocycline: far beyond an antibiotic

10.1111/bph.12139 · 2013 · External reference

Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability

10.1371/journal.pone.0031111 · 2012 · External reference

Diagnosis and management of HIV-associated neuropathy

10.1016/j.ncl.2008.04.001 · 2008 · External reference

10.1016/j.phrs.2012.10.013

10.1016/j.phrs.2012.10.013 · 2013 · External reference

Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor

10.1016/0005-2760(95)00157-8 · 1995 · External reference

Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada

2014 · External reference

European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management

10.1002/ejp.1297 · 2018 · External reference

Cannabidivarin is anticonvulsant in mouse and rat

10.1111/j.1476-5381.2012.02207.x · 2012 · External reference

Cannabis and pain: a clinical review

10.1089/can.2017.0017 · 2017 · External reference

A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy

10.1016/j.pain.2012.12.023 · 2013 · External reference

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716

10.1001/archpsyc.58.4.322 · 2001 · External reference

Unresolved reference

External reference

HIV neuropathy

10.1097/coh.0000000000000103 · 2014 · External reference

JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy

10.1016/j.phrs.2014.09.008 · 2014 · External reference

Oxidative metabolism of endocannabinoids by COX2

10.2174/1381612043453081 · 2004 · External reference

A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain

10.1016/j.jpainsymman.2013.02.018 · 2014 · External reference

Metabolism of the endocannabinoid anandamide: open questions after 25 years

10.3389/fnmol.2017.00166 · 2017 · External reference

Cannabinoid receptors and endocannabinoids: evidence for new players

10.1007/bf02854900 · 2006 · External reference

Meta-analysis of the association between the level of cannabis use and risk of psychosis

10.1093/schbul/sbw003 · 2016 · External reference

Indomethacin plus minocycline coadministration relieves chemotherapy and antiretroviral drug-induced neuropathic pain in a cannabinoid receptors-dependent manner

10.1016/j.jphs.2019.02.007 · 2019 · External reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

10.1038/346561a0 · 1990 · External reference

Marijuana use is not associated with changes in opioid prescriptions or pain severity among people living with HIV and chronic pain

10.1097/qai.0000000000001998 · 2019 · External reference

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

10.1016/s0140-6736(07)61162-3 · 2007 · External reference

Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society

10.1155/2014/754693 · 2014 · External reference

Pharmacologic management of chronic neuropathic pain: review of the Canadian Pain Society consensus statement

2017 · External reference

Cannabis‐based medicines for chronic neuropathic pain in adults

2018 · External reference

Antihyperalgesic activities of endocannabinoids in a mouse model of antiretroviral-induced neuropathic pain

10.3389/fphar.2017.00136 · 2017 · External reference

Molecular characterization of a peripheral receptor for cannabinoids

10.1038/365061a0 · 1993 · External reference

Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS

10.1111/bph.12411 · 2014 · External reference

Role of indomethacin in acute pain and inflammation management: a review of the literature

10.3810/pgm.2014.07.2787 · 2014 · External reference

Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy

10.1016/j.neuropharm.2014.11.024 · 2015 · External reference

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study

10.1002/syn.20050 · 2004 · External reference

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

10.1016/j.pain.2007.08.028 · 2007 · External reference

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

10.1196/annals.1369.052 · 2006 · External reference

Frequency of cannabis use and medical cannabis use among persons living with HIV in the United States: findings from a nationally representative sample

10.1521/aeap.2018.30.2.169 · 2018 · External reference

A potted history

10.1038/525s10a · 2015 · External reference

Supraspinal interaction between HIV-1-gp120 and cannabinoid analgesic effectiveness

10.1007/s00210-018-1533-1 · 2018 · External reference

Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: involvement of cannabinoid CB1 receptors

10.1038/srep10541 · 2015 · External reference

Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa

10.1186/1471-2458-8-255 · 2008 · External reference

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

10.1371/journal.pone.0014433 · 2010 · External reference

Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate

10.1016/s0021-9258(18)33114-4 · 1983 · External reference

Unresolved reference

External reference

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: a systematic review and network meta-analysis

10.1016/j.japh.2019.07.015 · 2020 · External reference

Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside

10.1016/j.nurt.2009.08.002 · 2009 · External reference

Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways

10.1021/cr2002799 · 2011 · External reference

Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes

10.1016/j.bcp.2003.12.003 · 2004 · External reference

HIV-related neuropathy: current perspectives

2013 · External reference

A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment

10.1002/j.1532-2149.2013.00445.x · 2014 · External reference

Antiallodynic effects of cannabinoid receptor 2 (CB2R) agonists on retrovirus infection-induced neuropathic pain

10.1155/2019/1260353 · 2019 · External reference

The current state of HIV and aging: findings presented at the 10th International Workshop on HIV and Aging

10.1089/aid.2020.0128 · 2020 · External reference

Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain

10.1080/10826084.2017.1416408 · 2018 · External reference

Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation

10.1016/j.brainres.2006.02.042 · 2006 · External reference

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

10.1006/bbrc.1995.2437 · 1995 · External reference

Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand

10.1046/j.1445-5994.2003.00401.x · 2003 · External reference

Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain

10.1016/j.biopha.2020.110456 · 2020 · External reference

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

10.1016/j.pain.2012.06.024 · 2012 · External reference

The religious and medicinal uses of Cannabis in China, India and Tibet

10.1080/02791072.1981.10471447 · 1981 · External reference

Effects on spasticity and neuropathic pain of an oral formulation of δ9-tetrahydrocannabinol in patients with progressive multiple sclerosis

10.1016/j.clinthera.2017.01.016 · 2018 · External reference

Identification and functional characterization of brainstem cannabinoid CB2 receptors

10.1126/science.1115740 · 2005 · External reference

HIV-associated neuropathic pain

10.2165/00023210-200519040-00005 · 2005 · External reference

Pain in clients attending a South African voluntary counseling and testing center was frequent and extensive but did not depend on HIV status

10.1097/qai.0000000000002248 · 2020 · External reference

Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy

10.1016/j.pain.2007.02.015 · 2007 · External reference

Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain

10.1093/brain/awm195 · 2007 · External reference

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy

10.1038/sj.bjp.0707326 · 2007 · External reference

Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels

10.1016/j.pain.2012.02.015 · 2012 · External reference

Analgesic effects of cannabinoids for chronic non-cancer pain: a systematic review and meta-analysis with meta-regression

10.1007/s11481-020-09905-y · 2020 · External reference

Cannabis use in HIV for pain and other medical symptoms

10.1016/j.jpainsymman.2004.07.011 · 2005 · External reference

Cannabis and Tourism: A Future Uk Industry Perspective

10.1108/jtf-10-2018-0064 · 2019 · External reference

Early medical use of cannabis

10.1038/363215a0 · 1993 · External reference

Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system

10.3390/ijms19030833 · 2018 · External reference